Award
NIH Reporter #1R21AG099768-01
Epigenetic age acceleration and differences among immune cell populations in people with and without HIV
Recipient
Vanderbilt University Medical Center
Award Amount
$519,500.00
Ceiling
$519,500.00
Awarded
May 13, 2026
Identifier
1R21AG099768-01
A 2-year R21 study by Vanderbilt University Medical Center to understand epigenetic age acceleration in HIV by examining immune cell populations and aging outcomes, funded by the National Institute on Aging.
Description
This study investigates how HIV infection and aging influence epigenetic clocks in immune cells and how these measures predict physical and cognitive aging outcomes. It aims to compare epigenetic age acceleration (EAA) across immune cell types in people with and without HIV, using cryopreserved PBMC samples and detailed clinical data.